Navigation Links
Cipla launches 3-in-1 AIDS drug in India

Cipla has launched an innovative combination of 3 HIV/AIDS drugs, Viraday that needs to be taken just once a day for effective treatment. //

The three anti-HIV drugs efavirenz 600 mg, tenofovir 300 mg and emtricitabine 200mg comprise the drug Viraday. Viraday, one tablet of which alone effectively treats a HIV infected person, eliminates the need for 3 separate medicines. This drug has some advantages like, it is less burdensome and it can be taken along with tuberculosis medicine, which could not be done previously.

This combination drug, that was previously available only in the U.S. and European countries, was first launched in India by Cipla on Thursday. In the U.S. and Europe this combination drug costs Rs. 52,800 a month, whereas Cipla will make it accessible at just Rs. 5,200 per month. This combination drug is less toxic than when the drugs are taken separately.

This breakthrough would improve the adherence-how faithfully patients stick to the course of treatment advised by the doctor. “This is a vital issue in HIV treatment to prevent the infection from reaching the advanced stage of AIDS,” said senior consultant in Internal Medicine at Indraprastha Apollo Hospital, Dr Nalin Nag. He said, “Viraday is very patient friendly, as it requires just one pill a day and freedom from the severe side effect of many other anti HIV drugs.”

The innovative treatment kits and the 3-in-1 pills introduced by Cipla will promote adherence and ease of use. Viraday is the most remarkable accomplishment of Cipla.

Cipla has brought down the price of HIV/AIDS drugs in international market. It supplies HIV/AIDS drugs to majority of African, South Asian, Latin American and several other developing countries.
YT
'"/>




Page: 1

Related medicine news :

1. Cipla holds talks with mining giant to supply AIDS drugs for South African workers
2. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
3. Cipla In India Can Manufacture Drug For Bird Flu
4. FDA Gives Preliminary Nod To Cipla And Sun Drugs
5. Ciplas HIV Drug Gets FDA Approval
6. Glaxo launches pills to help smokers quit in 7-12 weeks
7. Dr Reddy’s Laboratories launches Hyalosy
8. GlaxoSmithKline launches diabetes and cancer drugs
9. YSR launches Operation Dengue
10. Is Diabetes the Leading Cause of Kidney Failure in India
11. AIDS Disaster in India is Imminent
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/22/2017)... ... 2017 , ... An inventor from Columbia, S.C., wants to offer people with ... damaged in a firework accident, so she couldn’t grip a pen properly," he said. ... then designed and created a prototype for the HELPEN HAND, a special pen that ...
(Date:5/22/2017)... (PRWEB) , ... May 22, 2017 , ... Faithfully following ... a body squatted, stretched, jumped, toned and shaped through fitness programs. It carries on ... of course, finished off with an irresistible, radiant smile. CDA has found ...
(Date:5/21/2017)... ... May 19, 2017 , ... Chris Cornell, 52, was found dead on the night of Wednesday, ... most respected lead singers in the rock industry would take his own life, but the ... investigates how mental illness played a role in the death of Chris Cornell . ...
(Date:5/21/2017)... , ... May 20, 2017 , ... ... corporate text designs created specifically for use in Final Cut Pro X. The ... all media productions. Pixel Film Studios’ ProParagraph Corporate will deliver a professional and ...
(Date:5/21/2017)... ... ... Florida Pain Relief Group, a division of Physician Partners of America (PPOA), ... Ave., Melbourne, on Monday, May 22. Initially the clinic will be supervised by Physician ... operates 23 pain management clinics in Florida and the Dallas-Fort Worth, Texas metro area, ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... , May 10, 2017 CSSi, the ... for the clinical research industry, is proud to announce ... . The new website features both enriched content and ... experience and enhances the company,s already well-established position as ... "After many months of hard work, ...
(Date:5/8/2017)... 2017 MACRA replaces the outdated sustainable ... service reimbursement. Black Book Research crowdsource-surveyed 8,845 physician practices ... The Market for MIPS Compliance Technology is Booming ... with 3 or more clinicians seek to buy Merit-Based ... the magnitude of the changes, the hunt is on ...
(Date:5/4/2017)... -- Fortuna Fix Inc. (" Fortuna "), a private, clinical-stage ... the need for embryonic and fetal stem cells by using ... Fortuna announced today the launch of its ... MD, PhD; Father Kevin FitzGerald , S.J., PhD; Col. ... James Giordano , PhD. "We are excited and ...
Breaking Medicine Technology: